Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
Company Information
About this company
Key people
Mariano Ucar Angulo
Chairman of the Board, Other External Director
Fabrizio Chines
Chief of Akantior & IOL Officer
Enrique Linares Plaza
Lead Independent Director
Carmen Basagoiti Pastor
Proprietary Director
Gonzalo Fernandez de Valderrama Iribarnegaray
Proprietary Director
Inigo Zavala Ortiz de la Torre
Proprietary Director
Eduardo Recoder De La Cuadra
Chief Executive Officer, Executive Director
Belen Amatriain Corbi
Independent Director
Iker Etxezarreta Fraile
Chief Financial Officer
Carlos Gutierrez Aguero
Chief People Officer
Alberto Fernandez Fernandez
Chief Marketing and Portfolio Strategy Officer
Isabel Najera Vazquez De Parga
Chief Scientific and Medical Officer
Mariana Soroa Zubiria
Deputy Director - Internal Audit and Compliance
Xavier Arnaud
Chief Business Development Officer
Helder Cassis
General Director of Portugal Unit
Click to see more
Key facts
- Shares in issue316.22m
- EPICFAE
- ISINES0134950F36
- LocationSpain
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap€1.48bn
- Employees2,671
- ExchangeMercado Continuo Espana
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.